Title: Genes associated with prostate cancer are differentially expressed in African American and European American men Authors and Affiliations:

Background: Despite more aggressive screening across all demographics and gradual declines in mortality related to prostate cancer (PCa) in the United States, disparities among populations on August 16, 2017. © 2013 American Association for Cancer Research. cebp.aacrjournals.org Downloaded from Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on March 20, 2013; DOI: 10.1158/1055-9965.EPI-12-1238

[1]  S. Srivastava,et al.  Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer. , 2012, Urology.

[2]  J. Vishwanatha,et al.  Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges , 2012, Journal of carcinogenesis.

[3]  P. Schultz,et al.  CXCR4 Expression in Prostate Cancer Progenitor Cells , 2012, PloS one.

[4]  H. Morgenstern,et al.  The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy , 2011, Prostate cancer.

[5]  A. Villers,et al.  Abnormal Expression of the ERG Transcription Factor in Prostate Cancer Cells Activates Osteopontin , 2011, Molecular Cancer Research.

[6]  S. Ha,et al.  Androgen receptor levels are upregulated by Akt in prostate cancer. , 2011, Endocrine-related cancer.

[7]  A. Mariotto,et al.  Improved estimates of cancer-specific survival rates from population-based data. , 2010, Journal of the National Cancer Institute.

[8]  A. Goel,et al.  Is central obesity, hyperinsulinemia and dyslipidemia associated with high-grade prostate cancer? A descriptive cross-sectional study , 2010, Indian journal of urology : IJU : journal of the Urological Society of India.

[9]  M. Loda,et al.  Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  W. Gerald,et al.  Copy number and gene expression differences between African American and Caucasian American prostate cancer , 2010, Journal of Translational Medicine.

[11]  H. Hakonarson,et al.  An integrated expression phenotype mapping approach defines common variants in LEP, ALOX15 and CAPNS1 associated with induction of IL-6 , 2009, Human molecular genetics.

[12]  M. Gerstein,et al.  Molecular sampling of prostate cancer: a dilemma for predicting disease progression , 2010, BMC Medical Genomics.

[13]  Yuh-Lin Wu,et al.  Glucosamine inhibits IL‐1β‐mediated IL‐8 production in prostate cancer cells by MAPK attenuation , 2009, Journal of cellular biochemistry.

[14]  E. Petricoin,et al.  Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness. , 2009, The Journal of urology.

[15]  W. Fu,et al.  Osteoblasts‐derived BMP‐2 enhances the motility of prostate cancer cells via activation of integrins , 2008, The Prostate.

[16]  Robyn L Prueitt,et al.  Tumor immunobiological differences in prostate cancer between African-American and European-American men. , 2008, Cancer research.

[17]  K. Malik,et al.  Angiotensin II-induced Akt activation is mediated by metabolites of arachidonic acid generated by CaMKII-stimulated Ca2(+)-dependent phospholipase A2. , 2005, American journal of physiology. Heart and circulatory physiology.

[18]  Xin Lin,et al.  Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells. , 2005, The Prostate.

[19]  G. Coetzee,et al.  Androgen Receptor Signaling , 2004, Cancer Research.

[20]  G. Sonnenberg,et al.  A novel pathway to the manifestations of metabolic syndrome. , 2004, Obesity research.

[21]  Timothy F. Donahue,et al.  Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. Ni,et al.  Androgen suppresses PML protein expression in prostate cancer CWR22R cells. , 2004, Biochemical and biophysical research communications.

[23]  J. Loscalzo,et al.  Effects of Race and Hypertension on Flow-Mediated and Nitroglycerin-Mediated Dilation of the Brachial Artery , 2001, Hypertension.

[24]  M. Banerjee,et al.  Should African‐American men be tested for prostate carcinoma at an earlier age than white men? , 1999, Cancer.

[25]  D. Grignon,et al.  Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[26]  A S Whittemore,et al.  Prostate-specific antigen as predictor of prostate cancer in black men and white men. , 1995, Journal of the National Cancer Institute.